Exopharm

Tryptamine Therapeutics, located in Camberwell, Victoria, is a clinical-stage biotechnology company dedicated to pioneering innovative solutions in psychedelic drug development aimed at enhancing patient care. The company focuses on addressing neuropsychiatric disorders through therapeutic dosing of synthetic psilocybin and IV-infused psilocin, which seeks to overcome the limitations associated with orally administered treatments.

Driven by a commitment to patient outcomes, Tryptamine Therapeutics is developing proprietary formulations and advanced dosing methods to improve the psychedelic experience for patients suffering from chronic pain and other conditions. With a strong management team and ongoing global patent pursuits, the company is on a mission to transform the treatment landscape for diseases with unmet medical needs.

Generated from the website